ABSTRACT: A pilot-scale membrane bioreactor (MBR) was installed and operated for one year at a Swiss hospital. It was fed an influent directly from the hospital's sanitary collection system. To study the efficiency of micropollutant elimination in raw hospital wastewater that comprises a complex matrix with micropollutant concentrations ranging from low ng/L to low mg/L, an automated on-line SPE-HPLC-MS/MS analytical method was developed. Among the 68 target analytes were: 56 pharmaceuticals
overall load elimination of all pharmaceuticals and metabolites in the MBR was 22%, as over 80% of the load was due to persistent iodinated contrast media. No inhibition by antibacterial agents or disinfectants from the hospital was observed in the MBR. The hospital wastewater was found to be a dynamic system in which conjugates of pharmaceuticals de-conjugate and biological transformation products are formed, which in some cases are pharmaceuticals themselves.
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INTRODUCTION
While in some countries (e.g. Japan, China, Greece) [1] [2] [3] wastewater from big hospitals is pre-treated or biologically treated on-site, in many other countries, including Switzerland, it is connected directly to a municipal sewer and treated at municipal wastewater treatment plants (WWTP). Treatment of the wastewater at the source has advantages of avoiding dilution due to mixing with the urban sewage and avoiding losses into the environment due to sewer leakage and combined sewer overflows. 4, 5 In case of hospital wastewater, concerns are to avoid spread of (multi-resistant or pathogenic) bacteria, viruses, and parasite eggs as well as to avoid input of pharmaceuticals, diagnostic agents and disinfectants.
Membrane bioreactors (MBR) can remove by retention more than 5 and 2 log units of bacteria and viruses, respectively. 3 Hospital wastewater treatment by MBR showed to be feasible in a German fullscale pilot study and over 95% elimination for four out of nine measured pharmaceuticals was achieved, although effluent concentrations were often higher than the target value of 100 ng/L. 6 Apart from the recent study from Germany, only scarce elimination efficiency data for few micropollutants in hospital wastewaters are currently available, 7 whereas considerably more hospital wastewater data is available on occurrence and contribution of hospitals to pharmaceutical loads. 1, [8] [9] [10] [11] [12] [13] [14] [15] [16] Even in other environmental studies than those focused on hospital wastewater, only a small subset of all pharmaceuticals that are in use has thus far been investigated. 17, 18 An ecotoxicological evaluation of the investigated hospital wastewater was published earlier. 17 To collect robust data on elimination efficiencies of multiple micropollutants from the complex matrix of hospital wastewater, proper tools need to be available. First, a suitable sampling strategy needs to be employed to ensure representative results. Secondly, the analytics should enable high sample throughput and ideally incorporate numerous micropollutants of interest. Nowadays, with the availability of sensitive mass spectrometers, pharmaceuticals and other micropollutants can be analyzed in environmental waters down to low or even sub-nanogram per liter levels. One of the trends in the environmental analysis of micropollutants is replacement of classical solid phase extraction by automated alternatives, such as on-line solid-phase extraction high performance liquid chromatography coupled with tandem mass spectrometry (SPE-HPLC-MS/MS) [19] [20] [21] or large-volume injection HPLC-MS/MS 22, 23 . The large volume injection and the on-line SPE are conceptually very similar (see SI, Figure S1 ). The advantages over classical SPE are cost-efficiency due to reusable pre-columns or cartridges, minimal sample handling, time-efficiency, and elimination of analyte losses and human malfunctioning in a multi-step SPE procedure -all resulting in easily achievable high sample throughput. The choice between large-volume injection and on-line SPE-HPLC-MS/MS is thus often only a question of the lab's experience and equipment.
Performance of biological treatment of hospital effluents can be influenced by inhibition of the biomass by disinfectants and antibacterial agents present in much higher concentrations in hospital wastewater than in municipal wastewater. A typical hospital uses tons of disinfectants per year. In Swiss hospitals ethanol, propanol, methyl ethyl ketone, and glutaraldehyde are used in the highest amounts (SI ,   Table S15 ). Beside these mostly easily degradable compounds the quaternary ammonia compounds (QACs) are important disinfectants -strongly adsorbing cationic compounds. QACs are eliminated by more than 90% in sewage treatment; however, they have also been shown to have cytotoxic effects. [24] [25] [26] QACs commonly used are benzalkonium chloride (BAC-C12-18, technical mixture of isomers C12, C14, C16, and C18) and dimethyldidecylammonium chloride (DDAC-C10) -see SI, Table S15 . As reported for those compounds in an Austrian study, QAC-derived risk to sensitive non-target organisms cannot be excluded. 26 The objective of this paper was to provide data on the general performance and micropollutant elimination efficiency of an on-site biological wastewater treatment at hospitals. To meet this objective:
(i) a pilot-scale MBR was installed to receive and treat wastewater originating in a Swiss hospital and was in continuous operation for one year; (ii) an efficient and representative sampling campaign was designed and employed to representatively collect influent and effluent samples from the MBR; and (iii)
an automated and robust on-line SPE-HPLC-MS/MS analytical method was developed and optimized to quantify the concentrations of approximately 68 target analytes including pharmaceuticals, human metabolites, and industrial chemicals. As disinfectants present in hospital wastewater at high levels have the potential to inhibit biological treatment, maximal tolerable concentration of the abundant QAC benzyldimethyldodecylammonium (BAC-C12) to prevent inhibition of nitrification was determined in a batch study and several QACs measured in the wastewater. The elimination efficiency of the present target micropollutants was determined from the loads of the MBR influent and effluent sampled continuously and flow-proportionally over 3 weeks. Sampling was adjusted to the hydraulic residence time of the MBR. De-conjugation and transformation processes in the sewer and the MBR were specifically addressed, as these abundant mechanisms are sometimes neglected or overlooked when evaluating elimination efficiencies of micropollutants. Oxygen concentration in the aerobic compartment was maintained by aeration at 3±2 mg/L.
MATERIALS AND METHODS

Pilot
Sampling.
A peristaltic pump (average flow rate <2 mL/min) was used for continuous, flow- Sample Preparation. Within 3-6 hours after each sampling day, the wastewater samples were filtered through a 0.7-µm GF/F glass-fiber filter (Whatman, Dassel, Germany) and further through a 0.2-µm regenerated cellulose filter (Sartorius AG, Göttingen, Germany). For the analysis of 68 micropollutants (Table S1 and S4), samples were diluted in ratio 1:100 and 1:10 with nanopure water or left undiluted, depending on the matrix (Table S9 ). Subsequently, 50 isotope labeled internal standards in three mixtures were spiked (Table S2 ). Prepared samples were stored at 4°C in the dark for 1-20 days before they were analyzed. For analysis, 20 mL of the filtered and internal standard containing sample in an amber glass vial was inserted into a cooled auto-sampler rack, and automatically acidified by formic acid (0.1% formic acid in a sample, v/v) just before injection into the on-line SPE-HPLC-MS/MS system to avoid hydrolysis.
Analytical method. The analytical hardware and the final SPE-HPLC-MS/MS method are described in SI, Page S18-S19. Shortly, in-house filled on-line SPE cartridge contained Isolute ENV + and Oasis HLB solid phase materials, HPLC column Atlantis T3 (Waters) was used for chromatographic separation, and a triple quadrupole mass spectrometer detector TSQ Quantum Ultra (Thermo Fisher Scientific) for detection. Loading of the sample to a loop, enrichment onto the SPE cartridge, elution and chromatographic run was automated simultaneously in three time steps with an already existing SPE-HPLC-MS/MS set-up used earlier for sulfonamides in surface waters. 20 Quality control (QC) was assured by measuring two transitions for each analyte and each internal standard, comparing retention time of an analyte with the retention time of the internal standard in each sample, duplicates, numerous blanks, and QC standards. Details on QC, uncertainty, relative recoveries, and limits of quantification can be found in the SI.
Elimination Efficiency Calculation. The term "elimination" refers in this study to the change in the load of a given substance in the effluent (SP-3) compared to the load in the influent (SP-1) usually determined over 3 weeks regardless of whether it is mineralized, transformed, or even formed in the system. Negative elimination efficiencies arise if a substance shows higher loads in the effluent compared to the influent (e.g. in case of de-conjugation of conjugates). Figure S4 contains a detailed description of the elimination efficiency calculation.
Disinfectants. Quaternary ammonia disinfectants were analyzed during one week in August 24 -September 1, 2009 at the Austrian Federal Environmental Agency as previously described. 27 The set-up of the inhibition batch study is described in the SI. Shortly, seven aerobic batches of activated sludge were spiked with the disinfectant BAC-C12 at increasing concentration in the range of 1-50 mg/L.
Oxygen consumption rates were used to assess the effect of a disinfectant on the nitrification process.
RESULTS AND DISCUSSION
Hospital wastewater specificity and the general performance of the MBR. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 suspended solids, and chlorides, however other general parameters were similar. 5 Significantly bigger differences than for general parameters are in the concentrations of certain pharmaceutical classes. For example in hospital wastewater we detected in average 32 µg/L of the antibiotic ciprofloxacin and up to 2600 µg/L of iodinated X-ray contrast media (ICM), which is around 70-times more than the concentrations reported in the municipal wastewater for ciprofloxacin, or hundreds of times for ICM. 28, 29 Elevated concentrations of antibiotics but also disinfectants that are used in hospitals in large amounts could cause bacterial inhibition in case of hospital wastewater treatment on-site. Most relevant disinfectant in that respect are QACs (Table S15) , as the alcohols, aldehydes and ketones used for disinfection in the highest amounts are well biodegradable.
Our results of the inhibition study with the quaternary ammonia disinfectant BAC-C12 show that its maximal tolerable concentration to prevent inhibition in the given hospital wastewater is 150 µg/L (SI, Page S54). Comparable results were obtained in an Austrian study where the tests were done with activated sludge from a municipal WWTP with no significant contribution of hospitals or industry. 30 The measured concentration of the mixture BAC-C12-18 in the wastewater of the Cantonal hospital of
Baden was 49±11 µg/L, of which 34±9 µg/L was BAC-C12. Those concentrations are more than 3-times below the determined maximal tolerable concentration and thus no inhibition of nitrification by BAC-C12 is expected. DDAC-C10 was found in concentrations 102±9 µg/L, also below inhibition concentrations. 30 Nevertheless, this might not apply to other hospitals as the disinfectant use routine and water consumption can vary greatly between hospitals and countries and a broad range of yearly loads of disinfectants per bed has been reported for European hospitals (SI , Table S16 ).
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The on-site wastewater treatment MBR was in operation at the Cantonal hospital of Baden for one year and ran under stable conditions during the entire period. The DOC and COD removal was 94% and 92%, respectively (SI , Table S11 ). Full nitrification (>99% N-elimination) and denitrification (>85%) was achieved. This shows that the hospital wastewater specificity does not significantly disturb biological processes in the MBR and a good performance can be maintained.
Tools for obtaining robust elimination data. Tables S1 and S3 contain very polar compounds such as ICM (log K ow around -2) as well as apolar compounds such as valsartan or ritonavir (log K ow above 4), and anionic, cationic, zwitterionic, and uncharged species are present at an arbitrary pH (Table S5 ). The aim of the study was to analyze all of the compounds with one automated multi-compound method to allow high sample throughput. When designing the method, the challenge was to find conditions that would provide satisfactory results for the majority of the analytes.
Analytical on-line SPE-HPLC-MS/MS method. The analytes of our study listed in
The conditions to be considered were: the SPE material or material combination, pH of the sample at loading, suitable SPE eluent which serves also as part of the HPLC mobile phase, SPE cartridge washing solvents, the time of valve switching, the HPLC column material and column dimensions, the HPLC mobile phase composition and the gradient. Additionally, the parameter that could be varied depending on the sample matrix was the volume of loaded sample (alternatively the dilution factor).
The major problems were encountered with the acidic ICM, as they were not retained well on most of the SPE materials, they eluted from the SPE cartridge in broad peaks and due to weak interactions with a chromatographic material they were not subject to sufficient focusing on the HPLC column. An improvement in the SPE retention was achieved by using combination of two SPE materials: an Isolute ENV + material as a main sorbent, on which problematic ICM retained well, but loading the sample first through the Oasis HLB material, on which most of the other analytes retained.
In total seven different SPE materials in eight different combinations and at three different pH values (pH 3, 7, 9) were investigated. The optimized method used a layer of ENV + and Oasis HLB materials, samples were loaded at pH 3, and eluted with methanol. The chromatographic separation run with methanol and water at pH 3 on an Atlantis T3 column (6 column materials tested). As the method was based on satisfactory conditions for all analytes, rather than on optimal conditions for each of the analytes, using available labeled internal standards for the majority of the analytes was crucial to obtain reliable results.
The relative recoveries of the final analytical method were in the range 80-120% for the majority of compounds in various wastewater matrices (SI, Table S9 ). Limits of quantification are listed in Table S10 -the sensitivity of the method satisfied or exceeded the requirements of the study for all the analytes with exception of three: dexamethasone, methylprednisolone, and fluoxetine (as discussed in SI, Page S41). Over 40 analytes could be quantified with an expanded analytical uncertainty smaller than 30% at a confidence interval of 95% (SI , Table S7 and Page S29). The compounds with high uncertainty were in general compounds without matching internal standards, for which the bias of relative recoveries and intraday precision are higher. Extremely high uncertainties were calculated for metamizole metabolites for which no matching internal standards were available and transformation in stock solutions in minor extend over longer time was observed. Further, iomeprol and iopamidol showed poor intraday precision due to poor interaction with SPE and chromatographic material. The uncertainty range for each compound is stated in the main result table (Table 1) .
Wastewater sampling.
For pharmaceuticals that are used relatively rarely and by a few patients (e.g.
cytostatic cyclophosphamide) non-representative sampling can occur when a single toilet flush generating an input pulse is missed or when the sampling event by chance happens only during a single toilet flush input pulse. As discussed in previous studies, even flow-proportional sampling with insufficient sampling frequency intervals can miss a toilet flush pulse and a sampling frequency of less than 1 min for hospital wastewater (less than 5 min for municipal wastewater), or continuous flowproportional sampling is recommended. 16, 32 We opted for long-term continuous flow-proportional sampling in this study. A tracer test showed that the MBR behaved like a fully mixed reactor and the hydraulic residence time in the MBR between the primary clarifier and the permeate tank was up to 98 hours (95 percentile, Figure S2 ). Due to long hydraulic residence time in the MBR, sampling of at least one week is necessary for calculation of reliable elimination efficiencies for pharmaceuticals that exhibit variable influent concentrations and are not easily biodegradable, e.g. iopromide or tramadol ( Figure 2 , and Figure S4 ). As shown in Figure 2 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 composite) vary due to strong variation of concentrations within week days from apparent no elimination to elimination of 60% with very high standard deviation. Such an influence of sampling strategies on the obtained results is crucial but often neglected. 32 If the elimination is calculated from weekly composite loads, it varies only between 29% and 33%, with standard deviation of less than 2%.
On the other hand, for easily degradable compounds like paracetamol, the individual composite samples of 48 or 72-hours show the same elimination efficiency as the elimination calculated from weekly influent and effluent loads, which is in both cases more than 99% elimination (see Figure 2 ).
Conjugates and Transformation Products
1.
Conjugates. Negative elimination efficiencies were observed for some pharmaceuticals that form conjugates and are not easily biodegradable, e.g. sulfadiazine, furosemide or propranolol (see Table S14 for the list of pharmaceuticals which form conjugates that are excreted in urine or feces). In general,
conjugates of some pharmaceuticals with glucuronic acid, sulfate, glutathione, or acetyl coenzyme A are formed in the human body during phase 2 metabolism to increase solubility and to facilitate excretion.
Excreted conjugates then decompose in the wastewater and during the wastewater treatment back into the parent pharmaceuticals and the effluent concentrations of the parent compound can be higher than those in the influent. Such an increase in the loads of the parent pharmaceuticals has been previously observed for sulfamethoxazole and others in municipal wastewater treatment plants 33, 34 and is expected to be even more common in hospital wastewater, as the travel time of conjugates between the source and the treatment is much shorter than it usually is for municipal WWTPs. Sulfamethoxazole as well as its conjugate N4-acetylsulfametaxazole were measured in this study. The elimination efficiency of sulfamethoxazole without consideration of de-conjugation is 7%, while the real elimination efficiency of sulfamethoxazole calculated from the sum of sulfamethoxazole and N4-acetylsulfamethoxazole in the influent and effluent is 36% (Table 1) . Literature studies report -280% to >98% elimination of sulfamethoxazole in municipal wastewater 35 , which suggests that several previous studies have ignored de-conjugation processes when calculating elimination efficiencies of sulfamethoxazole. For easily biodegradable compounds that form conjugates (e.g. paracetamol or morphine) significant decreases of load after the MBR treatment is observed, despite de-conjugation. However, we observed an increase of paracetamol loads due to de-conjugation in the primary clarifier, where the microbial activity is lower compared to the MBR (Figure 2) . A study of Mohle et al. 36 showed that in a batch experiment with 1:10 diluted activated sludge, paracetamol glucuronide was completely de-conjugated to paracetamol within 5 hours. The paracetamol concentration reached a maximum after 8 hours and was further biologically degraded within 18 hours after the beginning of the experiment.
Transformation products.
Besides the formation of pharmaceuticals by de-conjugation, loads of human drugs or metabolites can increase during biological treatment if biological or abiotic reaction processes result in their formation from other compounds. For example, atenolol acid is formed during wastewater treatment as a microbially-mediated reaction product of atenolol 37, 38 whereas it is also found in the influent as the human metabolite of metoprolol 39 . Another example is the human metabolite D617 which is also formed during wastewater treatment from verapamil 40, 41 . Oseltamivir carboxylate, a human active metabolite of oseltamivir, is also the biodegradation products formed during the wastewater treatment 42 . The same could also apply to oxazepam -a pharmaceutical on its own but also a human metabolite of diazepam. The true elimination of such substances is difficult to assess, as both formation and elimination are occurring. Further, we also observed load increases of clindamycin, oseltamivir, phenazone, and primidone after biological treatment. The compounds are pharmaceuticals for which formation of conjugates is not reported. For oseltamivir, the negative elimination efficiency exhibits a high variation due to the lack of data points and therefore no further conclusion can be drawn.
An increase of clindamycinand phenazone loads after municipal wastewater treatment has been previously reported without giving a possible cause. [43] [44] [45] We assume that phenazone is formed from 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 other pharmaceuticals 46 ) , and is biologically degradable under aerobic conditions. 47 The measured loads of phenazone in the hospital wastewater were too high to come from the phenazone consumption, which further supports the hypothesis of phenazone formation from metamizole, or metamizole metabolites.
This means that phenazone is either a minor human metabolite of metamizole or it is formed in the sewer before reaching the MBR. As for clindamycin formation, we assume transformation of the main human metabolite clindamycin sulfoxide back to clindamycin in the denitrification process, as an analogous process was previously described for biodegradation of dimethyl to dimethyl sulfide sulfoxide by Hyphomicrobium denitrificans.
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MBR Elimination Efficiencies.
It is known that many factors can influence reported elimination efficiencies. Among them are the sludge age and concentration, existence of anoxic and anaerobic compartments, composition of the wastewater, inoculum source and character, technical set-up (conventional activated sludge treatment or MBR), operating temperature, pH, and conductivity -as previously addressed in literature and not discussed further here. 35 Additionally, as already discussed above, the sampling strategy, although often neglected, plays a major role. Keeping this in mind, comparison of elimination data has to be handled with care.
Literature on elimination efficiencies for the target analytes investigated within this study in hospital wastewater treatment is available for a few compounds in an MBR system with a sludge age of 100 days, 6 and are compared in the following accordingly. Furthermore, results of this study are compared to available literature values for conventional activated sludge and MBR municipal wastewater treatment (SI , Table S12 ). Additionally to data comparison, it is pointed out for individual compounds whether the elimination is due to biological elimination or sorption (SI, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1. Iodinated X-ray contrast media. This group of pharmaceuticals used in remarkably high quantities consists of compounds with similar structures which are persistent to biological treatment. Out of 6 measured substances all with the exception of iohexol were detected in the majority of influent samples and in µg/L-mg/L levels, with effluent concentrations of the same order of magnitude. The highest elimination efficiency within this pharmaceutical class was detected for iopromide (31%), while the elimination was negligible for the other ICM. Detected elimination is rather due to biodegradation than due to sorption to activated sludge, as the compounds are too polar to adsorb readily and biotransformation products have been previously identified. 49, 50 Reported data from municipal wastewater treatment are in a broad range 35 into which elimination efficiencies from this study fit. While ICM are not toxic themselves, the main environmental concern is their persistency and the formation of toxic disinfection by-products in case of chlorination or chloramination, as ICM are found in ambient waters used as feed water for drinking water production. 51 
Antibiotics and other antiinfectives. Eleven out of twelve measured antibiotics (antibacterials) were
eliminated with efficiencies below 60%, while 96% elimination was detected for trimethoprim. All available literature data for trimethoprim report much lower elimination than determined in our study, as well as low K d and K biol values (Tables S12 and S13 ). Trimethoprim elimination was found to be dependent on the sludge age, 52 what can explain the high elimination observed in the hospital MBR. .
Clindamycin and the sulfonamides are formed, rather than eliminated, as discussed in the section on transformation products and conjugates, respectively. Reported elimination of sulfamethoxazole varies to a high extend from one WWTP to another, even if de-conjugation from N4-acetylsulfamethoaxazole is taken into account (Table S12) . Norfloxacin, ciprofloxacin, and metronidazole were eliminated by around 50%. Fluoroquinolones are mainly eliminated by sorption to sludge, 53 and the lower elimination in the hospital MBR is probably due to the lower sludge production in MBR than in conventional activated sludge. Ciprofloxacin and metronidazole elimination of 60-96% and <30%, respectively was previously reported for municipal wastewaters, 35, 54 and 80% and 100% for hospital wastewater MBR 6 .
The elimination of macrolides azithromycin, clarithromycin, and erythromycin (sum of erythromycin 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and erythromycin-H 2 O) was ranging from 20% to less than 60%. Complete elimination of clarithromycin in hospital wastewater MBR was reported, 6 pointing to an influence of sludge age as previously observed for clarithromycin. 52 Minor or no elimination was observed for the antiviral oseltamivir, its metabolite oseltamivir carboxylate, and the antimycotic fluconazole, while the antiviral ritonavir was eliminated by over 78%. The reported elimination efficiencies are comparable with the available municipal WWTP data (Table S12) , although no data were found for ritonavir, distinguished by Escher et al. to have a high risk quotient. loads were decreased by more than 92% after the MBR treatment. Mefenamic acid was found to also partly sorb to sludge. 55 Our results are well comparable with municipal WWTP literature data for the majority of pharmaceuticals from this class (Table S12) . Tramadol elimination up to 35% was previously reported for municipal wastewaters 56 and 75%for a hospital wastewater MBR. 6 Elimination of diclofenac varies to a high extend from one WWTP to another (see Table S12 ), and Beier et al. also
found only 20% elimination in their hospital wastewater MBR. 6 Sludge age itself was found to have no influence on the elimination in some studies, 6, 57 whereas others found diclofenac elimination to increase with higher sludge age; 5, 58, 59 the factors that influence elimination are therefore still unclear. Phenazone formation, possibly from metamizole metabolites, is discussed in the section on transformation products.
No literature for biological elimination efficiencies of 4-methylaminoantipyrine from wastewater was found, although a study with river water and natural river water biofilms reports its rapid degradation. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 (bezafibrate, verapamil, and valsartan) were eliminated by over 80%. These data mostly compare well with the municipal WWTP literature data (Table S12) . Propranolol is the only beta-blocker forming conjugates 46 and was rather formed than eliminated in our MBR system. For atenolol a relative high elimination was observed (99%), and elimination in conventional municipal WWTP (0-96%) and in municipal MBR (57-97%) was found to vary a lot from site to site (Table S12) for municipal WWTPs. [62] [63] [64] The measured antiepileptics, with exception of levetiracetam (95%), were very persistent to biological treatment (<23%). Carbamazepine was not eliminated at all, as observed in municipal WWTPs 35 and in the hospital wastewater MBR. 6 Gabapentin elimination (23%) differs from municipal WWTP literature data, where elimination of above 99% is reported. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 or 80% together) than in municipal WWTP studies where the elimination was less than 40% in a conventional activated sludge treatment, however similar in MBR (61%). 65, 66 Methylbenzotriazole was measured as the sum of 4-methylbenzotriazole and 5-methylbenzotriazole because the two isomers were chromatographically not fully separated. The peak height ratio between the easily degradable 5-methylbenzotriazole and more persistent 4-methylbenzotriazole was 1.33±0.06 and 1.34±0.07 in SP-1 and SP-2, respectively, while after the MBR treatment only the peak of 4-methylbenzotriazole was visible. In the technical mixture of methylbenzotriazole the two isomers occur in the ratio of 1.2 -1.3.
This suggests that if the hospital uses only the technical mixture with the given isomer ratio, the two isomers in the studied hospital wastewater did not degrade during the short traveling time in the hospital sewer or during approximately 1 day in the primary clarifier. These findings for hospital wastewater differ from the findings in municipal wastewater, where the isomer ratio of 0.62 was found in a German study. 66 Further, while we found 9-times more methylbenzotriazole than benzotriazole, two studies of influents of municipal WWTPs from Germany and Switzerland report 3 -70 times more benzotriazole than methylbenzotriazole. 66, 67 8. Sum of all measured pharmaceuticals and metabolites. All target pharmaceuticals and metabolites detected in the MBR influent summed up to 1.15 kg/day and an overall elimination of 22% was observed. However, 0.94 kg/day of this load (82%) is due to ICM which are generally persistent to biological treatment and only 2% elimination was found for their sum. When only pharmaceuticals and metabolites without ICM are considered, there is an overall mass elimination of 90%. Such a high elimination was achieved despite the fact that only 11 compounds were eliminated by more than 90%, while 20 compounds were eliminated by less than 20%. This was caused by the presence of a few compounds occurring in high quantities which were eliminated well e.g. paracetamol, ciprofloxacin, and the metamizole metabolites which sum up to almost 90% of the load.
The on-site biological wastewater treatment of hospital wastewater by MBR is insufficient to eliminate the majority number of the target pharmaceuticals (especially ICM, antibiotics, and antiepileptics) as well as insufficient to eliminate most of the pharmaceutical load (due to ICM). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Nevertheless, biological treatment is necessary as a step for DOC elimination, if further on-site treatment of hospital wastewater is considered (e.g. ozonation, advanced oxidation processes, membrane processes, activated carbon, or photo-degradation).
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